Additionally, miR-635 expression exhibited a negative correlation with the levels of GS, Gln, and PXN-AS1 in samples from CML patients who were resistant to Imatinib (Fig. 6g–i). The gene discussed is PXN; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.